These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 85192)

  • 61. Fields of application of continuous subcutaneous insulin infusion in the treatment of diabetes and implications in the use of rapid-acting insulin analogues.
    Pitocco D; Rizzi A; Scavone G; Tanese L; Zaccardi F; Manto A; Ghirlanda G
    Minerva Endocrinol; 2013 Sep; 38(3):321-8. PubMed ID: 24126552
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A reduction in severe hypoglycaemia in type 1 diabetes in a randomized crossover study of continuous intraperitoneal compared with subcutaneous insulin infusion.
    Liebl A; Hoogma R; Renard E; Geelhoed-Duijvestijn PH; Klein E; Diglas J; Kessler L; Melki V; Diem P; Brun JM; Schaepelynck-Bélicar P; Frei T;
    Diabetes Obes Metab; 2009 Nov; 11(11):1001-8. PubMed ID: 19740082
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Education of the diabetic patient--insulin injection and lipodystrophy].
    Gilbert C
    Soins; 2000-2001 Dec-Jan; (651):23-5. PubMed ID: 11301548
    [No Abstract]   [Full Text] [Related]  

  • 64. Comparison of Insulin Pump Therapy and Multiple Daily Injections Insulin Regimen in Patients with Type 1 Diabetes During Ramadan Fasting.
    Alamoudi R; Alsubaiee M; Alqarni A; Saleh Y; Aljaser S; Salam A; Eledrisi M
    Diabetes Technol Ther; 2017 Jun; 19(6):349-354. PubMed ID: 28296467
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Respective contributions of the method of insulin injection and its absorption by subcutaneous route in the etiopathogenesis of unstable diabetes].
    Home PD
    Journ Annu Diabetol Hotel Dieu; 1995; ():243-55. PubMed ID: 7602885
    [No Abstract]   [Full Text] [Related]  

  • 66. Intraperitoneal insulin in continuous ambulatory peritoneal dialysis (CAPD): clinical aspects.
    Triolo G; Carta Q; Salomone M; Dani F; Passarino G; Boggio Bertinet D; Segoloni GP; Vercellone A
    Life Support Syst; 1983; 1 Suppl 1():454-6. PubMed ID: 6400733
    [No Abstract]   [Full Text] [Related]  

  • 67. ABC of diabetes. Continuous subcutaneous insulin infusion.
    Pickup JC
    Br Med J (Clin Res Ed); 1982 Jul; 285(6334):49-50. PubMed ID: 6805809
    [No Abstract]   [Full Text] [Related]  

  • 68. Continuous blood glucose monitoring in insulin-treated diabetes.
    Mirouze J; Collard F; Selam JL; Pham J
    Horm Metab Res; 1977; Suppl 7():77-88. PubMed ID: 873445
    [No Abstract]   [Full Text] [Related]  

  • 69. Nutrient regulation of insulin secretion in human subjects.
    Kiphis DM
    Diabetes; 1972; 21(2 Suppl):606-16. PubMed ID: 5066238
    [No Abstract]   [Full Text] [Related]  

  • 70. EFFECT OF INSULIN ON GLUCOSE PRODUCTION AND UTILIZATION IN DIABETES.
    KALANT N; CSORBA TR; HELLER N
    Metabolism; 1963 Dec; 12():1100-11. PubMed ID: 14100281
    [No Abstract]   [Full Text] [Related]  

  • 71. Experimentally induced hyperketonemia and insulin secretion in the dog.
    Pi-Sunyer F; Campbell RG; Hashim SA
    Metabolism; 1970 Apr; 19(4):263-70. PubMed ID: 5435860
    [No Abstract]   [Full Text] [Related]  

  • 72. Chronic insulin overtreatment.
    Smith RF; Moore RA; Asplin CM; Hockaday TD
    Lancet; 1979 Sep; 2(8143):634-5. PubMed ID: 90294
    [No Abstract]   [Full Text] [Related]  

  • 73. [Use of the subcutaneous route].
    Millet M; Goenaga M; Garde C; Carrera JA
    Aten Primaria; 2001 Dec; 28(10):694. PubMed ID: 11784493
    [No Abstract]   [Full Text] [Related]  

  • 74. Matched glucose responses to insulin administered subcutaneously and intravenously. Evidence for subcutaneous inactivation of insulin.
    Stevenson RW; Tsakok TI; Parsons JA
    Diabetologia; 1980 May; 18(5):423-6. PubMed ID: 7000596
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Insulin responses to varying profiles of subcutaneous insulin infusion: kinetic modelling studies.
    Kraegen EW; Chisholm DJ
    Diabetologia; 1984 Mar; 26(3):208-13. PubMed ID: 6370771
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Comparison on intravenous and subcutaneous insulin infusions in man.
    Katsilambros N; Verykokidou H; Philipides P; Moiras G; Daikos GK
    Lancet; 1979 Mar; 1(8116):609-10. PubMed ID: 85192
    [No Abstract]   [Full Text] [Related]  

  • 77. Insulin via continuous subcutaneous infusion.
    Pickup JC; Keen H; Stevenson RW; Parsons JA; Alberti KG; White M; Kohner EM
    Lancet; 1978 Nov; 2(8097):988-9. PubMed ID: 82007
    [No Abstract]   [Full Text] [Related]  

  • 78. Insulin antibody binding in diabetes mellitus and factitious hypoglycemia.
    Palumbo PJ; Molnar GD; Taylor WF; Moxness KE; Tauxe WN
    Mayo Clin Proc; 1969 Oct; 44(10):725-37. PubMed ID: 5344806
    [No Abstract]   [Full Text] [Related]  

  • 79. Continuous subcutaneous insulin infusion or subcutaneous insulin injections.
    Turner RC; Ward EA; Phillips MA; Dornan TL; Ward GM; Hockaday TD
    Lancet; 1979 Sep; 2(8140):481. PubMed ID: 89550
    [No Abstract]   [Full Text] [Related]  

  • 80. [Causes and the principles of treatment in insulin-dependent diabetes mellitus (type I)].
    Waldhäusl W
    Pol Tyg Lek; 1982 Dec; 37(51-52):1591-4. PubMed ID: 6763993
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.